iNova Pharmaceuticals
↗Singapore, Singapore
iNova Pharmaceuticals is a leading multinational pharmaceutical and consumer healthcare company that develops, markets, and sells a wide range of market-leading over-the-counter (OTC) and prescription medicines. The company operates in over 20 countries across Asia, Australia, New Zealand, and Africa, with a growing presence in the Middle East and Europe.
iNova focuses on high-growth consumer health categories including cough, cold and flu, throat care, skin care, and weight management. The company is known for its portfolio of iconic brands such as Difflam, Duro-Tuss, and Betadine. iNova follows a strategy of growth through both organic innovation and the acquisition of established brands from larger pharmaceutical companies.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Consumer Healthcare & Specialty Pharma
SIZE & FINANCIALS
Employees:501-1000
Revenue:$300M-$500M
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Acquired
Total Raised:$1.3B (Enterprise Value at TPG Buyout)
Investors:TPG Capital, Pacific Equity Partners (PEP), Abu Dhabi Investment Authority (ADIA)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Topical formulations, Oral solids/liquids
Active Trials:12
Trial Phases:Phase 2: 2 | Phase 3: 4 | Phase 4: 6
FDA Approvals:5
EMA Approvals:3
CORPORATE STRUCTURE
Parent Company:TPG Capital (Majority)
Acquired By:TPG Capital (Majority Owner) (2022-11-01)
Subsidiaries:iNova Pharmaceuticals (Australia) Pty Ltd, iNova Pharmaceuticals (South Africa) (Pty) Ltd, iNova Pharmaceuticals (Philippines) Inc.
Key Partnerships:Mundipharma (Asset acquisition), Bausch Health (Legacy licensing), GSK/Haleon (Commercial partnerships)
COMPETITION
Position:Leader
Competitors:Haleon, Reckitt Benckiser, Sanofi Consumer Healthcare, Bayer, Johnson & Johnson (Kenvue)
LEADERSHIP
Key Executives:
Dan Spira - CEO
Andrew Davis - Chief Business Development / M&A Officer
Sacha Ernst - President AMENA
Board Members:Dan Spira, Joel Thickins (TPG), Terry Miu Neeland (PEP)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of iNova Pharmaceuticals and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with iNova Pharmaceuticals. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.